A detailed history of High Mark Wealth Management LLC transactions in Dexcom Inc stock. As of the latest transaction made, High Mark Wealth Management LLC holds 2,926 shares of DXCM stock, worth $220,152. This represents 0.11% of its overall portfolio holdings.

Number of Shares
2,926
Previous 3,036 3.62%
Holding current value
$220,152
Previous $344,000 43.02%
% of portfolio
0.11%
Previous 0.21%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$64.0 - $116.06 $7,040 - $12,766
-110 Reduced 3.62%
2,926 $196,000
Q2 2024

Jul 29, 2024

BUY
$110.31 - $140.45 $1,764 - $2,247
16 Added 0.53%
3,036 $344,000
Q1 2024

Apr 26, 2024

SELL
$114.22 - $140.1 $4,340 - $5,323
-38 Reduced 1.24%
3,020 $418,000
Q4 2023

Jan 22, 2024

SELL
$75.49 - $124.16 $11,398 - $18,748
-151 Reduced 4.71%
3,058 $379,000
Q3 2023

Oct 18, 2023

BUY
$86.06 - $137.93 $19,793 - $31,723
230 Added 7.72%
3,209 $299,000
Q4 2022

Feb 01, 2023

SELL
$84.98 - $122.67 $4,758 - $6,869
-56 Reduced 1.85%
2,979 $337,000
Q3 2022

Oct 21, 2022

BUY
$76.35 - $94.18 $229 - $282
3 Added 0.1%
3,035 $244,000
Q2 2022

Jul 19, 2022

BUY
$67.99 - $132.89 $154,609 - $302,191
2,274 Added 300.0%
3,032 $226,000
Q1 2022

Apr 25, 2022

BUY
$94.08 - $130.2 $94 - $130
1 Added 0.13%
758 $388,000
Q4 2021

Jan 20, 2022

BUY
$129.87 - $162.82 $259 - $325
2 Added 0.26%
757 $406,000
Q3 2021

Nov 01, 2021

SELL
$106.71 - $143.18 $960 - $1,288
-9 Reduced 1.18%
755 $413,000
Q4 2020

Jan 27, 2021

SELL
$78.0 - $104.5 $1,014 - $1,358
-13 Reduced 1.67%
764 $282,000
Q2 2020

Jul 22, 2020

SELL
$62.68 - $105.34 $20,872 - $35,078
-333 Reduced 30.0%
777 $315,000
Q4 2019

Mar 19, 2020

BUY
$36.62 - $57.29 $40,648 - $63,591
1,110 New
1,110 $242,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track High Mark Wealth Management LLC Portfolio

Follow High Mark Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Mark Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Mark Wealth Management LLC with notifications on news.